Somatic mutations in PTPN11 contribute to childhood malignancies, among which juvenile myelomonocytic leukemia (JMML) represents the archetypal disorder resulting from RAS signaling upregulation5,9–12. This evidence concerns the gene PTPN11 and juvenile myelomonocytic leukemia.